𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Consensus Conference on the Classification of Ductal Carcinoma of the Breast, April 22–25, 1999

✍ Scribed by Gordon F. Schwartz; Lawrence J. Solin; Ivo A. Olivotto; Virginia L. Ernster; Peter I. Pressman; The Consensus Conference Committee

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
77 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Consensus conference on the classificati
Consensus conference on the classification of ductal carcinoma in Situ
📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

## Presented at the Consensus Conference on the Because it has been documented that only a minority of patients Classification of Ductal Carcinoma In Situ, Phildevelop invasive cancer after excision of DCIS, some physicians have adelphia, Pennsylvania, April 25-28, 1997. been treating selected pat

Consensus conference on the classificati
Consensus conference on the classification of ductal carcinoma in Situ
✍ Robert J. Rosser 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

OR: odds ratio; CI: confidence interval. a Estimates are from multiple logistic regression equations, including terms for center, age, gender, education, total alcohol intake, and family history of colorectal carcinoma. b Reference category. c The sum does not add up to the total because some values

Breast conservation therapy in the Unite
Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma
✍ DeAnn Lazovich; Cam C. Solomon; David B. Thomas; Roger E. Moe; Emily White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of breast conserv